SLU-PP-332 – 5mg

SLU-PP-332 is a synthetic small molecule agonist of estrogen related receptors alpha and gamma (ERRα and ERRγ). Orphan nuclear receptors that regulate mitochondrial biogenesis, oxidative metabolism, and skeletal muscle energy substrate utilization without interacting with classical estrogen receptors. iLab Pharma’s formulation supplies 5mg as a lyophilized vial, a significantly higher concentration presentation than the F40 Biotech 500mcg tablet format, providing researchers with a reconstitute compound supply suited to parenteral administration research, in vitro cell culture applications, and protocols examining ERR agonist activity at concentration points beyond what the oral tablet format’s unit dose supports.

The 5mg lyophilized vial and 500mcg oral tablet serve distinct research purposes within CSD’s SLU-PP-332 range. The oral tablet format’s gastrointestinal absorption pathway introduces first pass metabolism variables that make it well suited to research examining oral bioavailability and systemic ERR agonist activity following standard administration. The lyophilized vial’s reconstitute format bypasses these gastrointestinal variables entirely, enabling precise solution concentration preparation for in vitro ERR receptor binding studies, comparative bioavailability research between oral and parenteral routes, and dose response protocols requiring concentration points above the 500mcg tablet unit dose. At 5mg total this vial provides ten times the compound per unit compared to a single tablet. Supporting extended research timelines and multi group experimental designs from a single vial supply.

SLU-PP-332’s ERRα and ERRγ co activation mechanism produces coordinated upregulation of oxidative phosphorylation gene expression, mitochondrial biogenesis, and fatty acid oxidation pathway activity in skeletal muscle tissue,  biological responses closely mirroring the transcriptional adaptations of endurance exercise training. This exercise mimetic profile through the ERR pathway is mechanistically distinct from AMPK mediated metabolic regulation compounds like MOTS-C and 5-Amino-1MQ in CSD’s range, making SLU-PP-332 a complementary research tool in comparative studies examining different molecular entry points into exercise adaptive metabolic regulation.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks SLU-PP-332 across two distinct formats, this iLab Pharma 5mg lyophilized vial and the F40 Biotech 500mcg 50 tablet oral presentation, giving researchers delivery route and concentration flexibility from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized vial at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside MOTS-C and 5-Amino-1MQ in comparative metabolic regulation and exercise mimetic compound studies. Browse CSD’s full peptide and research compound range for complete sourcing.